Communication: Correlation of Point of Care SARS-CoV-2 Serological Assay with Quantitative ELISA.
Ann Clin Lab Sci
; 50(6): 852-854, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: covidwho-984501
ABSTRACT
Due to the COVID-19 pandemic, the Food and Drug Administration issued an Emergency Use Authorization to permit developers of certain serological tests to market their product prior to a comprehensive review. Nonetheless, the reliability of these assays is of great importance in order to be useful as a tool in estimating the relative proportions of different populations that have been exposed to SARS-CoV-2. We provide a sampling of 145 individuals from an ambulatory setting simultaneously tested with a qualitative point of care rapid finger prick Lateral Wave® IgM and IgG assay and a sample for the Mayo Clinic enzyme linked immunosorbent assay (ELISA) IgM/IgG antibody assay. Significant discrepancies did exist between the purported antibody responses as demonstrated by each assay.
Buscar en Google
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Inmunoglobulina G
/
Inmunoglobulina M
/
Ensayo de Inmunoadsorción Enzimática
/
Sistemas de Atención de Punto
/
SARS-CoV-2
/
COVID-19
/
Anticuerpos Antivirales
Tipo de estudio:
Estudios diagnósticos
/
Investigación cualitativa
Límite:
Humanos
Idioma:
Inglés
Revista:
Ann Clin Lab Sci
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS